BlackRock, Inc. 13D and 13G filings for Atea Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-24 09:46 am Purchase | 2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | BlackRock Inc. BLK | 9,443,887 11.300% | 605,872 (+6.86%) | Filing |
| 2023-11-07 3:33 pm Purchase | 2023-10-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | BlackRock Inc. BLK | 8,838,015 10.600% | 804,443 (+10.01%) | Filing |
| 2023-01-24 1:56 pm Purchase | 2022-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | BlackRock Inc. BLK | 8,033,572 9.600% | 2,252,375 (+38.96%) | Filing |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | BlackRock Inc. BLK | 5,781,197 7.000% | 5,781,197 (New Position) | Filing |